18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: A cohort study

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Harambat, Jérôme ^a,b   Fassinou, Patricia ^c,d   Becquet, Renaud ^a,b   Touré, Pety ^c   Rouet, François ^c   Dabis, François ^b   Msellati, Philippe ^e   Blanche, Stéphane ^f   Timité Konan, Marguerite ^d   Salamon, Roger ^a,b   Leroy, Valériane ^a,b   Welffens Ekra, Christiane ^g   Bequet, Laurence ^g   Ekouévi, Didier K ^g   Tonwe Gold, Besigin ^g   Viho, Ida ^g   Allou, Gérard ^g   Castetbon, Katia ^g   Dequae Merchadou, Laurence ^g   Sakarovitch, Charlotte ^g   Touchard, Dominique ^g   Amani Bosse, Clarisse ^g   Ayekoe, Ignace ^g   Bédikou, Gédéon ^g   Coulibaly, Nacoumba ^g   Danel, Christine ^g   Horo, Apollinaire ^g   Likikouët, Ruffin ^g   Toure, Hassan ^g   Inwoley, André ^g   Touré, Ramata ^g   Aka Dago, Hortense ^g   Sihé, Alphonse ^g   Agbo, Hélène ^g   Brou, Hermann ^g   Desgrées Du Loû, Annabel ^g   Tijou Traoré, Annick ^g   Zanou, Benjamin ^g   Delfraissy, Jean François ^g   Lepage, Philippe ^g   Mandelbrot, Laurent ^g   Rouzioux, Christine ^g   more..

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; BREAST MILK; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; DEATH; FEMALE; GESTATION PERIOD; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KAPLAN MEIER METHOD; LIVE BIRTH; LOG RANK TEST; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; NEUTROPENIA; PREGNANT WOMAN; PRESCHOOL CHILD; PROBABILITY; PROPORTIONAL HAZARDS MODEL; SHORT COURSE THERAPY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYMPTOM; THROMBOCYTOPENIA; TREATMENT DURATION; VIRUS LOAD; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTE D'IVOIRE; DISEASE TRANSMISSION; EARLY DIAGNOSIS; MALE; MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; COTE D'IVOIRE; DISEASE TRANSMISSION, VERTICAL; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEVERITY OF ILLNESS INDEX; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 44949145151     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-169     Document Type: Article

References (43)

1. Antiretroviral drugs and the prevention of mother-to-child transmission in resource-limited settings. Recommendations for a public health approach (2005 revision). Technical Reference Group, Geneva, Switzerland, 28-29th June 2005. World Health Organisation, Geneva, WHO 2005 4
2. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? V Leroy C Sakarovitch M Cortina-Borja J McIntyre H Coovadia F Dabis ML Newell J Saba G Gray C Ndugwa C Kilewo A Massawe P Kituuka P Okong A Grulich H von Briesen J Goudsmit G Biberfeld G Haverkamp GJ Weverling JM Lange, AIDS 2005 19 16 1865 1875 10.1097/01.aids.0000188423.02786.55 16227795
3. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007. World Health Organisation UNAIDS UNICEF, Geneve, World Health Organisation 2007 82
4. AIDS Epidemic Update. http://www.unaids.org/en/HIV_data/2006GlobalReport/ default.asp
5. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. ML Newell H Coovadia M Cortina Borja N Rollins P Gaillard F Dabis, Lancet 2004 364 9441 1236 1243 10.1016/S0140-6736(04)17140-7 15464184
6. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. S Blanche M Tardieu A Duliege C Rouzioux F Le Deist K Fukunaga M Caniglia C Jacomet A Messiah C Griscelli, Am J Dis Child 1990 144 11 1210 1215 1978551
7. Natural history of HIV type 1 infection in children: a five-year prospective study in Rwanda. R Spira P Lepage P Msellati P Van de Perre V Leroy A Simonon E Karita F Dabis, Pediatrics 1999 104 D1 D9.e56 10.1542/peds.104.5.e56
8. Enquête Démographique et de Santé Côte d'Ivoire 1998-1999. Rapport préliminaire. Ministère de la Planification et de la Programmation du Développement Institut National de la Statistique, Abidjan, and D, Inc. HSMI, 1999
9. 18-month mortality and perinatal exposure to zidovudine in West Africa. F Dabis N Elenga N Méda V Leroy I Viho O Manigart L Dequae-Merchadou P Msellati I Sombié for the DITRAME Study Group, AIDS 2001 15 771 779 10.1097/00002030-200104130-00013 11371692
10. Disease in children infected with HIV in Abidjan, Côte d'Ivoire. SB Lucas CS Peacock A Hounnou K Brattegaard K Koffi M Honde J Andoh J Bell KM De Cock, BMJ 1996 312 7027 335 338 8611829
11. Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children. SM Graham, Int J Tuberc Lung Dis 2005 9 6 592 602 15971385
12. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. SZ Wiktor M Sassan-Morokro AD Grant L Abouya JM Karon C Maurice G Djomand A Ackah K Domoua A Kadio A Yapi P Combe O Tossou TH Roels EM Lackritz D Coulibaly KM De Cock IM Coulibaly AE Greenberg, Lancet 1999 353 1469 1475 10.1016/S0140-6736(99)03465-0 10232312
13. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. X Anglaret G Chêne A Attia S Toure S Lafont P Combe K Manlan T N'Dri-Yoman R Salamon and the Cotrimo-CI study group, Lancet 1999 353 1463 1468 10.1016/S0140-6736(98)07399-1 10232311
14. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. J Mermin J Lule JP Ekwaru S Malamba R Downing R Ransom F Kaharuza D Culver F Kizito R Bunnell A Kigozi D Nakanjako W Wafula R Quick, Lancet 2004 364 9443 1428 1434 10.1016/S0140-6736(04)17225-5 15488218
15. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. C Chintu GJ Bhat AS Walker V Mulenga F Sinyinza K Lishimpi L Farrelly N Kaganson A Zumla SH Gillespie AJ Nunn DM Gibb, Lancet 2004 364 9448 1865 1871 10.1016/S0140-6736(04)17442-4 15555666
16. UNAIDS: Use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Recommendations and operational issues. Geneva, UNAIDS 2000 http://data.unaids.org/Publications/IRC-pub04/recommendation_en.pdf
17. WHO HIV prevention and treatment guidelines. Guidelines for co-trimoxazole prophylaxis for HIV-related infections in children, adults and adolescents in resource-limited settings: recommendations for a public health approach. World Health Organisation, Geneva, WHO 2006 1 68
18. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. F Dabis L Bequet DK Ekouevi I Viho F Rouet A Horo C Sakarovitch R Becquet P Fassinou L Dequae-Merchadou C Welffens-Ekra C Rouzioux V Leroy, AIDS 2005 19 3 309 318 15718842
19. 18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission. V Leroy DK Ekouevi R Becquet I Viho L Dequae-Merchadou B Tonwe-Gold F Rouet C Sakarovitch A Horo M Timite-Konan C Rouzioux F Dabis, PLoS ONE 2008 3 2 e1645 18286200 10.1371/journal.pone.0001645
20. Early diagnosis of paediatric HIV-1 infection among African breast- fed children using a quantitative plasma HIV RNA assay. F Rouet C Montcho C Rouzioux V Leroy P Msellati JB Kottan B You I Viho F Dabis, AIDS 2001 15 1849 1856 10.1097/00002030-200109280-00015 11579248
21. Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting. F Rouet DK Ekouevi ML Chaix M Burgard A Inwoley TD Tony C Danel X Anglaret V Leroy P Msellati F Dabis C Rouzioux, J Clin Microbiol 2005 43 6 2709 2717 15956387 10.1128/JCM.43.6.2709-2717.2005
22. Six months efficacy, tolerance and acceptability of a short regimen of oral zidovudine in reducing vertical transmission of HIV in breast-fed children. A double blind placebo controlled multicentre trial, ANRS049a, Côte d'Ivoire and Burkina Faso. F Dabis P Msellati N Meda C Welffens-Ekra B You O Manigart V Leroy A Simonon M Cartoux P Combe A Ouangre R Ramon O Ky-Zerbo C Montcho R Salamon C Rouzioux P Van de Perre L Mandelbrot for the DITRAME Study Group, Lancet 1999 353 786 792 10.1016/S0140-6736(98)11046-2 10459959
23. 15-month efficacy of oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group, Lancet 1999 354 2050 2051 10.1016/S0140-6736(99)04388-3 10636375
24. Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. N Meda V Leroy I Viho P Msellati S Yaro L Mandelbrot C Montcho O Manigart F Dabis, AIDS 2002 16 17 2323 2328 10.1097/00002030-200211220-00013 12441805
25. Acceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through breast milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire. R Becquet DK Ekouevi I Viho C Sakarovitch H Toure K Castetbon N Coulibaly M Timite-Konan L Bequet F Dabis V Leroy, J Acquir Immune Defic Syndr 2005 40 5 600 608 10.1097/01.qai.0000171726.17436.82 16284538
26. Acceptability of Formula-Feeding to Prevent HIV Postnatal Transmission, Abidjan, Cote d'Ivoire: ANRS 1201/1202 Ditrame Plus Study. V Leroy C Sakarovitch I Viho R Becquet DK Ekouevi L Bequet F Rouet F Dabis M Timite-Konan, J Acquir Immune Defic Syndr 2007 44 1 77 86 10.1097/01.qai.0000243115.37035.97 17031317
27. Première Conférence de Consensus en thérapeutique anti-infectieuse. Cotrimaxazole en prophylaxie primaires des infections opportunistes chez les patients infectés par le VIH en Côte d'Ivoire: Abidjan, Côte d'Ivoire. Société Ivoirienne de Pathologie Infectieuse et Tropicale 1999
28. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1- infected children. F Rouet C Sakarovitch P Msellati N Elenga C Montcho S Blanche C Rouzioux F Dabis V Leroy, Pediatrics 2003 112 4 E289 E297 10.1542/peds.112.4.e289 14523214
29. Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa. V Leroy JM Karon A Alioum ER Ekpini P van de Perre AE Greenberg P Msellati M Hudgens F Dabis SZ Wiktor, AIDS 2003 17 10 1493 1501 10.1097/00002030-200307040-00010 12824787
30. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. V Leroy JM Karon A Alioum ER Ekpini N Méda AE Greenberg P Msellati M Hudgens F Dabis S Wiktor for the West Africa PMTCT Study Group, AIDS 2002 16 4 631 641 10.1097/00002030-200203080-00016 11873008
31. Measure DHS, 1998 South Africa demographic and health survey. National Department of Health, Medical Research Council, Cape Town 2002
32. No benefit of early cessation of breastfeeding at 4 months on HIV-free survival of infants born to HIV-infected mothers in Zambia: the Zambia Exclusive Breastfeeding Study. M Sinkala, Fourteenth Conference on Retroviruses and Opportunistic Infections, February 25-28 2007 Los Angeles, USA 2007 abstract 74
33. WHO HIV and Infant feeding technical consultation held on behalf of the inter-agency task team (IATT) on prevention of HIV infections in pregnant women, mothers, and their infants. Consensus statement. World Health Organisation, Geneva 2006 5
34. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children. EM Obimbo DA Mbori-Ngacha JO Ochieng BA Richardson PA Otieno R Bosire C Farquhar J Overbaugh GC John-Stewart, Pediatr Infect Dis J 2004 23 6 536 543 10.1097/01.inf.0000129692.42964.30 15194835
35. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus. HJ Zar A Dechaboon D Hanslo P Apolles KG Magnus G Hussey, Pediatr Infect Dis J 2000 19 7 603 607 10.1097/00006454-200007000-00004 10917216
36. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. DD Ruffini SA Madhi, AIDS 2002 16 1 105 112 10.1097/00002030-200201040-00013 11741168
37. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa. A Coutsoudis K Pillay E Spooner HM Coovadia L Pembrey ML Newell, S Afr Med J 2005 95 5 339 345 15931449
38. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. JT Boerma KA Stanecki ML Newell C Luo M Beusenberg GP Garnett K Little JG Calleja S Crowley JY Kim E Zaniewski N Walker J Stover PD Ghys, Bull World Health Organ 2006 84 2 145 150 10.2471/BLT.05.025189 16501733
39. Increasing Antiretroviral Drug Access for Children With HIV infection. ICH Commitee on Pediatric AIDS, Pediatrics 2007 119 838 845 10.1542/peds.2007- 0273 17403860
40. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. A Faye J Le Chenadec C Dollfus I Thuret D Douard G Firtion E Lachassinne M Levine J Nicolas F Monpoux J Tricoire C Rouzioux M Tardieu MJ Mayaux S Blanche, Clin Infect Dis 2004 39 11 1692 1698 10.1086/425739 15578372
41. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. E Chiappini L Galli PA Tovo C Gabiano GC Gattinara A Guarino R Badolato C Giaquinto C Lisi M de Martino, Aids 2006 20 2 207 215 10.1097/01.aids.0000200529.64113.3e 16511413
42. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? ML Newell D Patel T Goetghebuer C Thorne, J Infect Dis 2006 193 7 954 962 10.1086/500842 16518757
43. Violari et al, ART initiated before 12 weeks reduces early mortality in young children HIV-infected infants: evidence from the children with HIV Early Antiretroviral Therapy (CHER) Study IAS, Sydney, Australia 2007